Company Search:
Advanced Search
Sponsored Links
Kyongbo Pharmaceutical Co Ltd Company Snapshot
Kyongbo Pharmaceutical Co Ltd operates within the Medicinals and botanicals sector. In addition to historical fundamental analyses, the complete report available to purchase compares Kyongbo Pharmaceutical Co Ltd with three other companies in this sector in South Korea: Ctc Bio, Incorporation. (2018 sales of 138.40 billion Korean Won [US$121.65 million] of which 74% was Animal Medication), Kyungdong Pharm (179.32 billion Korean Won [US$157.62 million] of which 93% was Medicine), and DaehanPharmaceutical (158.72 billion Korean Won [US$139.52 million] of which 100% was manufacture and distribution of pharmace).

Sales Analysis. During the year ended December of 2018, sales at Kyongbo Pharmaceutical Co Ltd were 201.34 billion Korean Won (US$176.98 million). This is an increase of 5.1% versus 2017, when the company's sales were 191.66 billion Korean Won. This was the fifth consecutive year of sales increases at Kyongbo Pharmaceutical Co Ltd (and since 2013, sales have increased a total of 24%).
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Kyongbo Pharmaceutical Co Ltd
  Stock Performance Chart for Kyongbo Pharmaceutical Co Ltd
  Stock Data: Recent Stock Performance:
  Current Price (4/12/2019): 10,700
(Figures in Korean Won)
1 Week 1.4%   13 Weeks -4.0%  
4 Weeks 5.9%   52 Weeks -34.2%  
Kyongbo Pharmaceutical Co Ltd Key Data:
  Ticker: 214390 Country: Korea (South)
  Exchanges: SEO Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Medicinals & Botanicals
  2018 Sales 201,343,595,542
(Year Ending Jan 2019).
Employees: 410
  Currency: Korean Won Market Cap: 255,803,402,000
  Fiscal Yr Ends: December Shares Outstanding: 23,906,860
  Share Type: Common Closely Held Shares: 15,213,176
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.